Insider and congress filings

Amgen Inc. (AMGN)

NASDAQ · Healthcare · 381 insider filings · 178 congress trades · last filed 6 days agoS&P 500Nasdaq 100

4
Open-market insider filings shown
1d
Median delay on the insider filings
within the two business day rule
0/4
Purchases and sales in the filings shown

About Amgen Inc.

from the company's filings and listing
Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers - General
Chief executive
Robert A. Bradway
Employees
31,500
Listed since
Jun 17, 1983
Market value
$211.2B
Price to earnings
24.1
Earnings per share
$16.19
Dividend yield
2.54%

www.amgen.com

Earnings

6 reported quarters · next on Nov 3, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Aug 4, 2026$6.29$5.62$10.1B$9.4BEPS beatRevenue beat
Q1 FY2026reported Apr 30, 2026$5.15$4.77$8.6B$8.6BEPS beatRevenue in line
Q4 FY2025reported Feb 3, 2026$5.29$4.73$9.9B$9.5BEPS beatRevenue beat
Q3 FY2025reported Nov 4, 2025$5.64$5.02$9.6B$9.0BEPS beatRevenue beat
Q2 FY2025reported Aug 5, 2025$6.02$5.28$9.2B$8.9BEPS beatRevenue beat
Q1 FY2025reported May 1, 2025$4.90$4.27$8.1B$8.1BEPS beatRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2025 · proxy filed Apr 7, 2026
ExecutiveSalaryStock awardsOtherTotal
Robert A. BradwayChief Executive Officer and President$1.9M$12.6M$10.2M$24.7M
James E. BradnerExecutive Vice President, Research and Development$1.2M$3.4M$4.0M$8.6M
Peter H. GriffithExecutive Vice President and Chief Financial Officer$1.2M$3.7M$3.7M$8.6M
Murdo GordonExecutive Vice President, Global Commercial Operations$1.2M$3.7M$3.6M$8.5M
David M. ReeseExecutive Vice President and Chief Technology Officer$1.3M$3.4M$3.6M$8.3M

The summary compensation table from the 2025 proxy statement, current executives only. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Blackrock, Inc.$17.9B49,362,016+4.8%9.14%
Vanguard Capital Management LLC$12.8B35,250,101+0.7%6.53%
State Street Corp$11.1B30,560,537+0.0%5.66%
Capital World Investors$10.5B29,075,329-0.7%5.38%
Invesco Ltd.$5.9B16,320,446+44.3%3.02%
Geode Capital Management, LLC$5.7B15,696,068+1.7%2.91%
Sixth Street Partners Management Company, L.P.$5.4B15,034,038+100.0%2.78%
Charles Schwab Investment Management Inc$5.4B15,034,038+17.7%2.78%
Vanguard Portfolio Management LLC$5.4B14,853,366+1.6%2.75%
Morgan Stanley$4.9B13,653,692-13.8%2.53%
Wells Fargo & Company/Mn$2.6B7,235,462+2.1%1.34%
Primecap Management Co$2.4B6,756,962-23.9%1.25%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next AMGN filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Open-market insider trades

4 filings of 381 on record
InsiderActionSharesPriceValueTrade dateDelay
Rachna KhoslaSVP, Business DevelopmentSold1,252$416.43$521KAug 13, 20260d
Rachna KhoslaSVP, Business DevelopmentSold2,000$412.57$825KAug 11, 20262d
Derek MillerSVP, Human ResourcesSold1,821$402.54$733KAug 6, 20261d
Nancy A. GrygielSVP & CCOSold1,000$402.16$402KAug 6, 20261d

One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.

Congress trades in AMGN

20 disclosures of 178 on record · median 18d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
David TaylorStockSale$1,001 - $15,000-11.1%S&P -0.5% · vs S&P 500 -10.7%Aug 26, 2026Sep 5, 202610d
Sheldon WhitehouseSpouseStockSale (Partial)$1,001 - $15,000-6.0%S&P -1.3% · vs S&P 500 -4.7%Aug 12, 2026Sep 2, 202621d
Ro KhannaStockPurchase$1,001 - $15,000+6.3%S&P +2.3% · vs S&P 500 +4.1%Jul 8, 2026Aug 7, 202630d
Ro KhannaStockSale$1,001 - $15,000+7.4%S&P +2.7% · vs S&P 500 +4.7%Jul 20, 2026Aug 7, 202618d
Alan ArmstrongSelfFiled lateStockSale (Full)$15,001 - $50,000+12.2%S&P +20.2% · vs S&P 500 -8.0%Mar 27, 2026Jul 21, 2026116d
Ro KhannaStockPurchase$1,001 - $15,000+19.2%S&P +0.4% · vs S&P 500 +18.8%Jun 2, 2026Jul 6, 202634d
Ro KhannaStockPurchase$1,001 - $15,000+12.5%S&P +1.6% · vs S&P 500 +10.9%Jun 16, 2026Jul 6, 202620d
Ro KhannaStockPurchase$1,001 - $15,000+8.1%S&P +2.1% · vs S&P 500 +6.0%Jun 30, 2026Jul 6, 20266d
David TaylorStockPurchase$1,001 - $15,000+11.9%S&P +3.4% · vs S&P 500 +8.6%Jun 5, 2026Jun 12, 20267d
Ro KhannaStockSale$15,001 - $50,000+19.9%S&P +3.2% · vs S&P 500 +16.8%May 15, 2026Jun 9, 202625d
Ro KhannaStockPurchase$15,001 - $50,000+16.4%S&P +1.6% · vs S&P 500 +14.9%May 27, 2026Jun 9, 202613d
Ro KhannaStockPurchase$15,001 - $50,000+18.6%S&P +5.8% · vs S&P 500 +12.8%May 1, 2026Jun 9, 202639d
Ro KhannaStockSale$15,001 - $50,000+13.6%S&P +6.8% · vs S&P 500 +6.8%Apr 24, 2026May 11, 202617d
Maria Elvira SalazarStockSale$15,001 - $50,000+10.1%S&P +7.4% · vs S&P 500 +2.8%Apr 17, 2026May 8, 202621d
Maria Elvira SalazarStockPurchase$15,001 - $50,000+12.8%S&P +16.5% · vs S&P 500 -3.7%Mar 24, 2026Apr 21, 202628d
Ro KhannaStockSale$15,001 - $50,000+12.1%S&P +20.7% · vs S&P 500 -8.5%Mar 30, 2026Apr 7, 20268d
Ro KhannaStockPurchase$15,001 - $50,000+2.2%S&P +10.9% · vs S&P 500 -8.7%Feb 24, 2026Mar 9, 202613d
David TaylorStockSale$1,001 - $15,000+3.2%S&P +10.6% · vs S&P 500 -7.4%Feb 26, 2026Mar 6, 20268d
Ro KhannaStockSale$15,001 - $50,000+13.5%S&P +10.6% · vs S&P 500 +2.9%Jan 23, 2026Feb 6, 202614d
David TaylorStockSale$1,001 - $15,000+14.1%S&P +9.8% · vs S&P 500 +4.3%Jan 29, 2026Feb 2, 20264d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Members of Congress reporting a position

23 members · estimate, as of Sep 10, 2026

23 members report a position (estimated). The largest estimated position is in the $500,001 - $1,000,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
John W. HickenlooperDemocrat · Senate$500,001 - $1,000,0002.3%
Cliff BentzRepublican · House$100,001 - $250,00013.5%
Steve CohenDemocrat · House$100,001 - $250,0005.6%
Rick W. AllenRepublican · House$100,001 - $250,0002.9%
Sheldon WhitehouseDemocrat · Senate$100,001 - $250,0000.6%
Scott FranklinRepublican · House$100,001 - $250,0002.9%
Jared MoskowitzDemocrat · House$50,001 - $100,0002.1%
Carol D. MillerRepublican · House$50,001 - $100,0003.8%
Debbie DingellDemocrat · House$50,001 - $100,0001.2%
Shelley Moore CapitoRepublican · Senate$50,001 - $100,0002.5%
Daniel MeuserRepublican · House$50,001 - $100,0002.5%
David TaylorRepublican · House$15,001 - $50,0002.2%
Jacky RosenDemocrat · Senate$15,001 - $50,0000.8%
Robert BresnahanRepublican · House$15,001 - $50,0000.3%
Marjorie Taylor GreeneRepublican · House$15,001 - $50,0001.0%
Gilbert Ray Cisneros, Jr.Democrat · House$15,001 - $50,0000.1%
Laura FriedmanDemocrat · House$15,001 - $50,0007.8%
Robert OnderRepublican · House$15,001 - $50,0000.8%
Harriet M. HagemanRepublican · House$15,001 - $50,0000.6%
Julie JohnsonDemocrat · House$1,001 - $15,0000.1%
Rick LarsenDemocrat · House$1,001 - $15,0001.6%
Virginia FoxxRepublican · House$1,001 - $15,0000.6%
Tommy TubervilleRepublican · Senate$1,001 - $15,0000.2%

A further 2 members report a position estimated under $1,000; those are not listed.

Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Awards, option exercises and gifts (20)
InsiderEventSharesDate
Rachna KhoslaSVP, Business DevelopmentOption exercise1,252Aug 13, 2026
Matthew C. BuschVP, Finance & CAOStock award730Aug 7, 2026
Charles M. HolleyDirectorStock award103Aug 7, 2026
Omar IshrakDirectorStock award85Aug 7, 2026
Michael V. DrakeDirectorStock award64Aug 7, 2026
Nancy A. GrygielSVP & CCOOption exercise2,970Aug 6, 2026
Derek MillerSVP, Human ResourcesOption exercise3,890Aug 6, 2026
Ellen Jamison KullmanDirectorStock award665May 19, 2026
Wanda M. AustinDirectorStock award665May 19, 2026
Mary E. KlotmanDirectorStock award665May 19, 2026
Tyler JacksDirectorStock award665May 19, 2026
Charles M. HolleyDirectorStock award665May 19, 2026
Greg C. GarlandDirectorStock award665May 19, 2026
Robert EckertDirectorStock award665May 19, 2026
Omar IshrakDirectorStock award665May 19, 2026
Michael V. DrakeDirectorStock award665May 19, 2026
Brian DrukerDirectorStock award665May 19, 2026
Amy E. MilesDirectorStock award665May 19, 2026
Jonathan P. GrahamEVP & Gen. Counsel & Sec.Tax withholding499May 7, 2026
Robert A. BradwayChairman, CEO and PresidentTax withholding2,079May 7, 2026

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

Questions

Are insiders buying or selling AMGN?

Across the 4 most recent open-market filings shown here, 0 were purchases and 4 were sales.

Which members of Congress have traded AMGN?

David Taylor, Sheldon Whitehouse, Ro Khanna, Alan Armstrong, Maria Elvira Salazar disclosed AMGN transactions in the filings shown here.

Which members of Congress hold AMGN?

23 members of Congress report a position in AMGN in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to John W. Hickenlooper, Cliff Bentz and Steve Cohen. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

Is AMGN in the S&P 500 or the Nasdaq 100?

Amgen Inc. is a current member of the S&P 500 and Nasdaq 100, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.

How quickly are AMGN trades disclosed?

Insider filings on this page reached the public a median of 1 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 18 days, against the 45 the STOCK Act allows.

How to read a Form 4

A DECISION THE INSIDER MADE

POpen-market purchase. Bought with their own money at the market price.
SOpen-market sale. Sold on the market. A sale marked scheduled was set up in advance under a Rule 10b5-1 plan, often months before.

COMPENSATION PLUMBING

AStock award. Granted as pay, not bought.
MOption exercise. Converting options already held into shares.
FTax withholding. Shares handed back to the company to pay the tax on a grant.
GGift. Given away, with no money changing hands.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track